{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T13:29:30Z","timestamp":1794835770612,"version":"4.9.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["332727"],"award-info":[{"award-number":["332727"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["267606"],"award-info":[{"award-number":["267606"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["285136"],"award-info":[{"award-number":["285136"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["287927"],"award-info":[{"award-number":["287927"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["274993"],"award-info":[{"award-number":["274993"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["332727"],"award-info":[{"award-number":["332727"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["332727"],"award-info":[{"award-number":["332727"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Ministry of Health and Care Services | Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["10357"],"award-info":[{"award-number":["10357"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Ministry of Health and Care Services | Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2019047"],"award-info":[{"award-number":["2019047"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Ministry of Health and Care Services | Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2019084"],"award-info":[{"award-number":["2019084"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Ministry of Health and Care Services | Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2019084"],"award-info":[{"award-number":["2019084"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Ministry of Health and Care Services | Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["10357"],"award-info":[{"award-number":["10357"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Ministry of Health and Care Services | Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2019047"],"award-info":[{"award-number":["2019047"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Ministry of Health and Care Services | Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["267606"],"award-info":[{"award-number":["267606"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Ministry of Health and Care Services | Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["10357"],"award-info":[{"award-number":["10357"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Ministry of Health and Care Services | Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["10357"],"award-info":[{"award-number":["10357"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Coalition for Epidemic Preparedness and Innovation (CEPI) grant to monitor vaccine responses in patients on immunosuppressive therapy"},{"name":"The Coalition for Epidemic Preparedness and Innovation (CEPI) grant to monitor 1024 vaccine responses in patients on immunosuppressive therapy."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Although vaccines are usually given intramuscularly, the intranasal delivery route may lead to better mucosal protection and limit the spread of respiratory virus while easing administration and improving vaccine acceptance. The challenge, however, is to achieve delivery across the selective epithelial cell barrier. Here we report on a subunit vaccine platform, in which the antigen is genetically fused to albumin to facilitate FcRn-mediated transport across the mucosal barrier in the presence of adjuvant. Intranasal delivery in conventional and transgenic mouse models induces both systemic and mucosal antigen-specific antibody responses that protect against challenge with SARS-CoV-2 or influenza A. When benchmarked against an intramuscularly administered mRNA vaccine or an intranasally administered antigen fused to an alternative carrier of similar size, only the albumin-based intranasal vaccine yields robust mucosal IgA antibody responses. Our results thus suggest that this needle-free, albumin-based vaccine platform may be suited for vaccination against respiratory pathogens.<\/jats:p>","DOI":"10.1038\/s41467-025-59353-6","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T05:03:09Z","timestamp":1746075789000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["An intranasal subunit vaccine induces protective systemic and mucosal antibody immunity against respiratory viruses in mouse models"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1725-4571","authenticated-orcid":false,"given":"Aina Karen","family":"Anthi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Kolderup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline Benno","family":"Vaage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Bern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3708-8125","authenticated-orcid":false,"given":"Sopisa","family":"Benjakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2744-3472","authenticated-orcid":false,"given":"Elias","family":"Tj\u00e4rnhage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6500-6807","authenticated-orcid":false,"given":"Fulgencio","family":"Ruso-Julve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjell-Rune","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1158-4879","authenticated-orcid":false,"given":"Heidrun Elisabeth","family":"Lode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Vaysburd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette","family":"Nilsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Leangen","family":"Herigstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri Aastedatter","family":"Sakya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9179-2116","authenticated-orcid":false,"given":"Lisa","family":"Tietze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0651-9329","authenticated-orcid":false,"given":"Diego","family":"Pilati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5248-6722","authenticated-orcid":false,"given":"Mari","family":"Nyquist-Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"D\u00fcrkoop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1719-7677","authenticated-orcid":false,"given":"Torleif Tollefsrud","family":"Gj\u00f8lberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stian","family":"Foss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0615-804X","authenticated-orcid":false,"given":"Morten C.","family":"Moe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0350-4602","authenticated-orcid":false,"given":"Benjamin E.","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael V.","family":"Wiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4769-6311","authenticated-orcid":false,"given":"David","family":"Nemazee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frode L.","family":"Jahnsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Torgils","family":"Vaage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9407-278X","authenticated-orcid":false,"given":"Kenneth A.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger","family":"Sandlie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2131-0334","authenticated-orcid":false,"given":"Leo C.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6285-3162","authenticated-orcid":false,"given":"Gunnveig","family":"Gr\u00f8deland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2445-1258","authenticated-orcid":false,"given":"Fridtjof","family":"Lund-Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1710-1628","authenticated-orcid":false,"given":"Jan Terje","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,1]]},"reference":[{"key":"59353_CR1","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1016\/S1473-3099(21)00472-2","volume":"22","author":"D Mostaghimi","year":"2022","unstructured":"Mostaghimi, D., Valdez, C. N., Larson, H. T., Kalinich, C. C. & Iwasaki, A. Prevention of host-to-host transmission by SARS-CoV-2 vaccines. Lancet Infect. Dis. 22, e52\u2013e58 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"59353_CR2","doi-asserted-by":"crossref","unstructured":"Lund, F. E. & Randall, T. D. Scent of a vaccine. Science 373, 397\u2013399 (2021).","DOI":"10.1126\/science.abg9857"},{"key":"59353_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103841","volume":"76","author":"A Alu","year":"2022","unstructured":"Alu, A. et al. Intranasal COVID-19 vaccines: From bench to bed. eBioMedicine 76, 103841 (2022).","journal-title":"eBioMedicine"},{"key":"59353_CR4","doi-asserted-by":"publisher","first-page":"5467","DOI":"10.1016\/j.vaccine.2006.12.001","volume":"25","author":"P Brandtzaeg","year":"2007","unstructured":"Brandtzaeg, P. Induction of secretory immunity and memory at mucosal surfaces. Vaccine 25, 5467\u20135484 (2007).","journal-title":"Vaccine"},{"key":"59353_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41541-023-00654-6","volume":"8","author":"JM Knisely","year":"2023","unstructured":"Knisely, J. M. et al. Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities\u2014workshop report. Npj Vaccines 8, 1\u20137 (2023).","journal-title":"Npj Vaccines"},{"key":"59353_CR6","doi-asserted-by":"publisher","unstructured":"Callaway, E. Inhaled COVID vaccines stop infection in its tracks in monkey trials. Nature https:\/\/doi.org\/10.1038\/d41586-023-04003-4 (2023).","DOI":"10.1038\/d41586-023-04003-4"},{"key":"59353_CR7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00281-023-00996-2","volume":"45","author":"F Krammer","year":"2024","unstructured":"Krammer, F. The role of vaccines in the COVID-19 pandemic: what have we learned? Semin. Immunopathol. 45, 451\u2013468 (2024).","journal-title":"Semin. Immunopathol."},{"key":"59353_CR8","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1056\/NEJMc2209651","volume":"387","author":"S Havervall","year":"2022","unstructured":"Havervall, S. et al. Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection. N. Engl. J. Med. 387, 1333\u20131336 (2022).","journal-title":"N. Engl. J. Med."},{"key":"59353_CR9","first-page":"e55","volume":"387","author":"F Zuo","year":"2022","unstructured":"Zuo, F., Marcotte, H., Hammarstrom, L. & Pan-Hammarstrom, Q. Mucosal IgA against SARS-CoV-2 Omicron Infection. N. Engl. J. Med. 387, e55 (2022).","journal-title":"N. Engl. J. Med."},{"key":"59353_CR10","doi-asserted-by":"publisher","first-page":"eabf1555","DOI":"10.1126\/scitranslmed.abf1555","volume":"13","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Enhanced SARS-CoV-2 neutralization by dimeric IgA. Sci. Transl. Med. 13, eabf1555 (2021).","journal-title":"Sci. Transl. Med."},{"key":"59353_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","volume":"19","author":"F Krammer","year":"2019","unstructured":"Krammer, F. The human antibody response to influenza A virus infection and vaccination. Nat. Rev. Immunol. 19, 383\u2013397 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"59353_CR12","doi-asserted-by":"publisher","first-page":"eabj0299","DOI":"10.1126\/science.abj0299","volume":"373","author":"KS Corbett","year":"2021","unstructured":"Corbett, K. S. et al. Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates. Science 373, eabj0299 (2021).","journal-title":"Science"},{"key":"59353_CR13","doi-asserted-by":"publisher","first-page":"eadd4853","DOI":"10.1126\/sciimmunol.add4853","volume":"0","author":"J Tang","year":"2022","unstructured":"Tang, J. et al. Respiratory mucosal immunity against SARS-CoV-2 following mRNA vaccination. Sci. Immunol. 0, eadd4853 (2022).","journal-title":"Sci. Immunol."},{"key":"59353_CR14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2315354120","volume":"121","author":"H Marcotte","year":"2024","unstructured":"Marcotte, H. et al. Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages. Proc. Natl Acad. Sci. USA 121, e2315354120 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59353_CR15","doi-asserted-by":"publisher","first-page":"eadn2364","DOI":"10.1126\/scitranslmed.adn2364","volume":"16","author":"J Declercq","year":"2024","unstructured":"Declercq, J. et al. Repeated COVID-19 mRNA-based vaccination contributes to SARS-CoV-2 neutralizing antibody responses in the mucosa. Sci. Transl. Med. 16, eadn2364 (2024).","journal-title":"Sci. Transl. Med."},{"key":"59353_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.0300-9475.2004.01382.x","volume":"59","author":"RJ Cox","year":"2004","unstructured":"Cox, R. J., Brokstad, K. A. & Ogra, P. Influenza virus: immunity and vaccination strategies. comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand. J. Immunol. 59, 1\u201315 (2004).","journal-title":"Scand. J. Immunol."},{"key":"59353_CR17","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1093\/infdis\/jiac065","volume":"226","author":"PF Wright","year":"2022","unstructured":"Wright, P. F. et al. Longitudinal systemic and mucosal immune responses to SARS-CoV-2 Infection. J. Infect. Dis. 226, 1204\u20131214 (2022).","journal-title":"J. Infect. Dis."},{"key":"59353_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32389-8","volume":"13","author":"K Sano","year":"2022","unstructured":"Sano, K. et al. SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals. Nat. Commun. 13, 5135 (2022).","journal-title":"Nat. Commun."},{"key":"59353_CR19","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41586-023-06809-8","volume":"624","author":"T Ye","year":"2023","unstructured":"Ye, T. et al. Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization. Nature 624, 630\u2013638 (2023).","journal-title":"Nature"},{"key":"59353_CR20","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41586-023-06951-3","volume":"626","author":"K McMahan","year":"2024","unstructured":"McMahan, K. et al. Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques. Nature 626, 385\u2013391 (2024).","journal-title":"Nature"},{"key":"59353_CR21","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1038\/s41590-024-01951-5","volume":"25","author":"M Gagne","year":"2024","unstructured":"Gagne, M. et al. Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates. Nat. Immunol. 25, 1913\u20131927 (2024).","journal-title":"Nat. Immunol."},{"key":"59353_CR22","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/d41586-022-02851-0","volume":"609","author":"E Waltz","year":"2022","unstructured":"Waltz, E. China and India approve nasal COVID vaccines \u2014 are they a game changer? Nature 609, 450\u2013450 (2022).","journal-title":"Nature"},{"key":"59353_CR23","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/d41586-022-02824-3","volume":"609","author":"E Waltz","year":"2022","unstructured":"Waltz, E. How nasal-spray vaccines could change the pandemic. Nature 609, 240\u2013242 (2022).","journal-title":"Nature"},{"key":"59353_CR24","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1073\/pnas.1012861108","volume":"108","author":"Z Li","year":"2011","unstructured":"Li, Z. et al. Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection. Proc. Natl Acad. Sci. USA. 108, 4388\u20134393 (2011).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"59353_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1084\/jem.20020400","volume":"196","author":"GM Spiekermann","year":"2002","unstructured":"Spiekermann, G. M. et al. Receptor-mediated Immunoglobulin G Transport Across Mucosal Barriers in Adult Life. J. Exp. Med. 196, 303\u2013310 (2002).","journal-title":"J. Exp. Med."},{"key":"59353_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1046\/j.1365-2567.1997.00326.x","volume":"92","author":"EJ Israel","year":"1997","unstructured":"Israel, E. J. et al. Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells. Immunology 92, 69\u201374 (1997).","journal-title":"Immunology"},{"key":"59353_CR27","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1172\/JCI6968","volume":"104","author":"BL Dickinson","year":"1999","unstructured":"Dickinson, B. L. et al. Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line. J. Clin. Invest. 104, 903\u2013911 (1999).","journal-title":"J. Clin. Invest."},{"key":"59353_CR28","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.immuni.2004.05.007","volume":"20","author":"M Yoshida","year":"2004","unstructured":"Yoshida, M. et al. Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity 20, 769\u2013783 (2004).","journal-title":"Immunity"},{"key":"59353_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jconrel.2015.12.033","volume":"223","author":"S Foss","year":"2016","unstructured":"Foss, S. et al. Enhanced FcRn-dependent transepithelial delivery of IgG by Fc-engineering and polymerization. J. Controlled Release 223, 42\u201352 (2016).","journal-title":"J. Controlled Release"},{"key":"59353_CR30","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.1021\/bi052628y","volume":"45","author":"C Chaudhury","year":"2006","unstructured":"Chaudhury, C., Brooks, C. L., Carter, D. C., Robinson, J. M. & Anderson, C. L. Albumin Binding to FcRn:\u2009 Distinct from the FcRn\u2212IgG Interaction. Biochemistry 45, 4983\u20134990 (2006).","journal-title":"Biochemistry"},{"key":"59353_CR31","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1002\/eji.200636556","volume":"36","author":"JT Andersen","year":"2006","unstructured":"Andersen, J. T., Dee Qian, J. & Sandlie, I. The conserved histidine 166 residue of the human neonatal Fc receptor heavy chain is critical for the pH-dependent binding to albumin. Eur. J. Immunol. 36, 3044\u20133051 (2006).","journal-title":"Eur. J. Immunol."},{"key":"59353_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1607","volume":"3","author":"JT Andersen","year":"2012","unstructured":"Andersen, J. T. et al. Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor. Nat. Commun. 3, 610 (2012).","journal-title":"Nat. Commun."},{"key":"59353_CR33","doi-asserted-by":"crossref","unstructured":"Bern, M. et al. An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologics. Sci. Transl. Med. 12, eabb0580 (2020).","DOI":"10.1126\/scitranslmed.abb0580"},{"key":"59353_CR34","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/nbt.1742","volume":"29","author":"L Ye","year":"2011","unstructured":"Ye, L., Zeng, R., Bai, Y., Roopenian, D. C. & Zhu, X. Efficient mucosal vaccination mediated by the neonatal Fc receptor. Nat. Biotechnol. 29, 158\u2013163 (2011).","journal-title":"Nat. Biotechnol."},{"key":"59353_CR35","doi-asserted-by":"publisher","first-page":"10542","DOI":"10.1128\/JVI.05441-11","volume":"85","author":"L Lu","year":"2011","unstructured":"Lu, L. et al. A neonatal fc receptor-targeted mucosal vaccine strategy effectively induces hiv-1 antigen-specific immunity to genital infection. J. Virol. 85, 10542\u201310553 (2011).","journal-title":"J. Virol."},{"key":"59353_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42796-0","volume":"14","author":"W Li","year":"2023","unstructured":"Li, W. et al. An FcRn-targeted mucosal vaccine against SARS-CoV-2 infection and transmission. Nat. Commun. 14, 7114 (2023).","journal-title":"Nat. Commun."},{"key":"59353_CR37","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.4049\/jimmunol.2100297","volume":"207","author":"SP Ochsner","year":"2021","unstructured":"Ochsner, S. P. et al. FcRn-targeted mucosal vaccination against influenza virus infection. J. Immunol. 207, 1310\u20131321 (2021).","journal-title":"J. Immunol."},{"key":"59353_CR38","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1158\/2326-6066.CIR-17-0607","volume":"6","author":"KD Moynihan","year":"2018","unstructured":"Moynihan, K. D. et al. Enhancement of peptide vaccine immunogenicity by increasing lymphatic drainage and boosting serum stability. Cancer Immunol. Res. 6, 1025\u20131038 (2018).","journal-title":"Cancer Immunol. Res."},{"key":"59353_CR39","doi-asserted-by":"publisher","first-page":"eabd8003","DOI":"10.1126\/sciimmunol.abd8003","volume":"6","author":"K Rakhra","year":"2021","unstructured":"Rakhra, K. et al. Exploiting albumin as a mucosal vaccine chaperone for robust generation of lung-resident memory T cells. Sci. Immunol. 6, eabd8003 (2021).","journal-title":"Sci. Immunol."},{"key":"59353_CR40","doi-asserted-by":"publisher","first-page":"eabn1413","DOI":"10.1126\/scitranslmed.abn1413","volume":"14","author":"BL Hartwell","year":"2022","unstructured":"Hartwell, B. L. et al. Intranasal vaccination with lipid-conjugated immunogens promotes antigen transmucosal uptake to drive mucosal and systemic immunity. Sci. Transl. Med. 14, eabn1413 (2022).","journal-title":"Sci. Transl. Med."},{"key":"59353_CR41","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/s41592-018-0179-8","volume":"15","author":"K Sikorski","year":"2018","unstructured":"Sikorski, K. et al. A high-throughput pipeline for validation of antibodies. Nat. Methods 15, 909\u2013912 (2018).","journal-title":"Nat. Methods"},{"key":"59353_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41541-022-00586-7","volume":"7","author":"TT Tran","year":"2022","unstructured":"Tran, T. T. et al. Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants. Npj Vaccines 7, 1\u201311 (2022).","journal-title":"Npj Vaccines"},{"key":"59353_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009246","volume":"17","author":"G Papa","year":"2021","unstructured":"Papa, G. et al. Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion. PLOS Pathog. 17, e1009246 (2021).","journal-title":"PLOS Pathog."},{"key":"59353_CR44","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41590-022-01163-9","volume":"23","author":"C Li","year":"2022","unstructured":"Li, C. et al. Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine. Nat. Immunol. 23, 543\u2013555 (2022).","journal-title":"Nat. Immunol."},{"key":"59353_CR45","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1074\/jbc.M109.081828","volume":"285","author":"JT Andersen","year":"2010","unstructured":"Andersen, J. T., Bekele Daba, M., Berntzen, G., Michaelsen, T. E. & Sandlie, I. Cross-species binding analyses of mouse and human neonatal fc receptor show dramatic differences in immunoglobulin g and albumin binding. J. Biol. Chem. 285, 4826\u20134836 (2010).","journal-title":"J. Biol. Chem."},{"key":"59353_CR46","doi-asserted-by":"publisher","first-page":"24277","DOI":"10.1074\/jbc.M113.463000","volume":"288","author":"JT Andersen","year":"2013","unstructured":"Andersen, J. T. et al. Single-chain variable fragment albumin fusions bind the neonatal Fc Receptor (FcRn) in a Species-dependent Manner implications for in vivo half-life evaluation of albumin fusion therapeutics. J. Biol. Chem. 288, 24277\u201324285 (2013).","journal-title":"J. Biol. Chem."},{"key":"59353_CR47","doi-asserted-by":"publisher","first-page":"13492","DOI":"10.1074\/jbc.M114.549832","volume":"289","author":"JT Andersen","year":"2014","unstructured":"Andersen, J. T. et al. Extending serum half-life of albumin by engineering neonatal fc receptor (fcrn) binding. J. Biol. Chem. 289, 13492\u201313502 (2014).","journal-title":"J. Biol. Chem."},{"key":"59353_CR48","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/bjh.17559","volume":"194","author":"S Lombardi","year":"2021","unstructured":"Lombardi, S. et al. Fusion of engineered albumin with factor IX Padua extends half-life and improves coagulant activity. Br. J. Haematol. 194, 453\u2013462 (2021).","journal-title":"Br. J. Haematol."},{"key":"59353_CR49","doi-asserted-by":"publisher","DOI":"10.1093\/pnasnexus\/pgad403","volume":"2","author":"S Benjakul","year":"2023","unstructured":"Benjakul, S. et al. A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal delivery. PNAS Nexus 2, pgad403 (2023).","journal-title":"PNAS Nexus"},{"key":"59353_CR50","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/intimm\/13.12.1551","volume":"13","author":"RJ Ober","year":"2001","unstructured":"Ober, R. J., Radu, C. G., Ghetie, V. & Ward, E. S. Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies. Int. Immunol. 13, 1551\u20131559 (2001).","journal-title":"Int. Immunol."},{"key":"59353_CR51","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1093\/intimm\/dxl110","volume":"18","author":"SB Petkova","year":"2006","unstructured":"Petkova, S. B. et al. Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease. Int. Immunol. 18, 1759\u20131769 (2006).","journal-title":"Int. Immunol."},{"key":"59353_CR52","doi-asserted-by":"publisher","first-page":"1829334","DOI":"10.1080\/19420862.2020.1829334","volume":"12","author":"BE Low","year":"2020","unstructured":"Low, B. E., Christianson, G. J., Lowell, E., Qin, W. & Wiles, M. V. Functional humanization of immunoglobulin heavy constant gamma 1 Fc domain human FCGRT transgenic mice. mAbs 12, 1829334 (2020).","journal-title":"mAbs"},{"key":"59353_CR53","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.freeradbiomed.2018.06.037","volume":"133","author":"H Kawabata","year":"2019","unstructured":"Kawabata, H. Transferrin and transferrin receptors update. Free Radic. Biol. Med. 133, 46\u201354 (2019).","journal-title":"Free Radic. Biol. Med."},{"key":"59353_CR54","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1124\/pr.54.4.561","volume":"54","author":"ZM Qian","year":"2002","unstructured":"Qian, Z. M., Li, H., Sun, H. & Ho, K. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol. Rev. 54, 561\u2013587 (2002).","journal-title":"Pharmacol. Rev."},{"key":"59353_CR55","doi-asserted-by":"publisher","first-page":"34583","DOI":"10.1074\/jbc.M114.587675","volume":"289","author":"KMK Sand","year":"2014","unstructured":"Sand, K. M. K. et al. Interaction with Both Domain I and III of Albumin Is Required for Optimal pH-dependent Binding to the Neonatal Fc Receptor (FcRn). J. Biol. Chem. 289, 34583\u201334594 (2014).","journal-title":"J. Biol. Chem."},{"key":"59353_CR56","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jconrel.2015.12.019","volume":"223","author":"D Viuff","year":"2016","unstructured":"Viuff, D. et al. Generation of a double transgenic humanized neonatal Fc receptor (FcRn)\/albumin mouse to study the pharmacokinetics of albumin-linked drugs. J. Controlled Release 223, 22\u201330 (2016).","journal-title":"J. Controlled Release"},{"key":"59353_CR57","doi-asserted-by":"publisher","first-page":"eabn8057","DOI":"10.1126\/scitranslmed.abn8057","volume":"14","author":"JP Evans","year":"2022","unstructured":"Evans, J. P. et al. Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection. Sci. Transl. Med. 14, eabn8057 (2022).","journal-title":"Sci. Transl. Med."},{"key":"59353_CR58","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1365-2567.2004.01958.x","volume":"113","author":"JM Woof","year":"2004","unstructured":"Woof, J. M. & Kerr, M. A. IgA function \u2013 variations on a theme. Immunology 113, 175\u2013177 (2004).","journal-title":"Immunology"},{"key":"59353_CR59","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/path.1877","volume":"208","author":"JM Woof","year":"2006","unstructured":"Woof, J. M. & Kerr, M. A. The function of immunoglobulin A in immunity. J. Pathol. 208, 270\u2013282 (2006).","journal-title":"J. Pathol."},{"key":"59353_CR60","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/imr.12332","volume":"268","author":"AM Brandsma","year":"2015","unstructured":"Brandsma, A. M., Jacobino, S. R., Meyer, S., ten Broeke, T. & Leusen, J. H. W. Fc receptor inside-out signaling and possible impact on antibody therapy. Immunol. Rev. 268, 74\u201387 (2015).","journal-title":"Immunol. Rev."},{"key":"59353_CR61","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cell.2020.08.026","volume":"183","author":"AO Hassan","year":"2020","unstructured":"Hassan, A. O. et al. A single-dose intranasal chad vaccine protects upper and lower respiratory tracts against SARS-CoV-2. Cell 183, 169\u2013184.e13 (2020).","journal-title":"Cell"},{"key":"59353_CR62","doi-asserted-by":"publisher","first-page":"100230","DOI":"10.1016\/j.xcrm.2021.100230","volume":"2","author":"AO Hassan","year":"2021","unstructured":"Hassan, A. O. et al. A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques. Cell Rep. Med. 2, 100230 (2021).","journal-title":"Cell Rep. Med."},{"key":"59353_CR63","doi-asserted-by":"crossref","unstructured":"Bricker, T. L. et al. A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters. Cell Rep. 36, 109400 (2021).","DOI":"10.1016\/j.celrep.2021.109400"},{"key":"59353_CR64","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/S1473-3099(21)00396-0","volume":"21","author":"S Wu","year":"2021","unstructured":"Wu, S. et al. Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial. Lancet Infect. Dis. 21, 1654\u20131664 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"59353_CR65","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1038\/d41591-022-00106-z","volume":"28","author":"T Carvalho","year":"2022","unstructured":"Carvalho, T. Intranasal COVID-19 vaccine fails to induce mucosal immunity. Nat. Med. 28, 2439\u20132440 (2022).","journal-title":"Nat. Med."},{"key":"59353_CR66","doi-asserted-by":"crossref","unstructured":"Zhang, Z. et al. Boosting with an aerosolized Ad5-nCoV elicited robust immune responses in inactivated COVID-19 vaccines recipients. Front. Immunol. 14, 1239179 (2023).","DOI":"10.3389\/fimmu.2023.1239179"},{"key":"59353_CR67","doi-asserted-by":"crossref","unstructured":"Madhavan, M. et al. Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial. eBioMedicine 85, 104298 (2022).","DOI":"10.1016\/j.ebiom.2022.104298"},{"key":"59353_CR68","doi-asserted-by":"publisher","first-page":"eabh0755","DOI":"10.1126\/scitranslmed.abh0755","volume":"13","author":"N van Doremalen","year":"2021","unstructured":"van Doremalen, N. et al. Intranasal ChAdOx1 nCoV-19\/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models. Sci. Transl. Med. 13, eabh0755 (2021).","journal-title":"Sci. Transl. Med."},{"key":"59353_CR69","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.02280-23","volume":"14","author":"D Bhavsar","year":"2023","unstructured":"Bhavsar, D. et al. Mucosal antibody responses to SARS-CoV-2 booster vaccination and breakthrough infection. mBio 14, e02280-23 (2023).","journal-title":"mBio"},{"key":"59353_CR70","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/0161-5890(96)00004-1","volume":"33","author":"S Popov","year":"1996","unstructured":"Popov, S. et al. The stoichiometry and affinity of the interaction of murine Fc fragments with the MHC class I-related receptor, FcRn. Mol. Immunol. 33, 521\u2013530 (1996).","journal-title":"Mol. Immunol."},{"key":"59353_CR71","doi-asserted-by":"publisher","first-page":"5497","DOI":"10.4049\/jimmunol.1401218","volume":"194","author":"A Grevys","year":"2015","unstructured":"Grevys, A. et al. Fc engineering of human igg1 for altered binding to the neonatal fc receptor affects fc effector functions. J. Immunol. 194, 5497\u20135508 (2015).","journal-title":"J. Immunol."},{"key":"59353_CR72","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/intimm\/13.8.993","volume":"13","author":"M Firan","year":"2001","unstructured":"Firan, M. et al. The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of \u03b3-globulin in humans. Int. Immunol. 13, 993\u20131002 (2001).","journal-title":"Int. Immunol."},{"key":"59353_CR73","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.clinbiochem.2009.12.001","volume":"43","author":"JT Andersen","year":"2010","unstructured":"Andersen, J. T., Daba, M. B. & Sandlie, I. FcRn binding properties of an abnormal truncated analbuminemic albumin variant. Clin. Biochem. 43, 367\u2013372 (2010).","journal-title":"Clin. Biochem."},{"key":"59353_CR74","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","volume":"26","author":"F Amanat","year":"2020","unstructured":"Amanat, F. et al. A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat. Med. 26, 1033\u20131036 (2020).","journal-title":"Nat. Med."},{"key":"59353_CR75","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1084\/jem.157.2.687","volume":"157","author":"L Staudt","year":"1983","unstructured":"Staudt, L. & Gerhard, W. Generation of antibody diversity in the immune response of BALB\/c mice to influenza virus hemagglutinin. I. Significant variation in repertoire expression between individual mice. J. Exp. Med. 157, 687\u2013704 (1983).","journal-title":"J. Exp. Med."},{"key":"59353_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-03061-x","volume":"9","author":"A Grevys","year":"2018","unstructured":"Grevys, A. et al. A human endothelial cell-based recycling assay for screening of FcRn targeted molecules. Nat. Commun. 9, 1\u201314 (2018).","journal-title":"Nat. Commun."},{"key":"59353_CR77","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1091\/mbc.e13-04-0174","volume":"24","author":"AW Weflen","year":"2013","unstructured":"Weflen, A. W. et al. Multivalent immune complexes divert FcRn to lysosomes by exclusion from recycling sorting tubules. Mol. Biol. Cell 24, 2398\u20132405 (2013).","journal-title":"Mol. Biol. Cell"},{"key":"59353_CR78","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.4049\/jimmunol.1300504","volume":"191","author":"G Grodeland","year":"2013","unstructured":"Grodeland, G., Mjaaland, S., Roux, K. H., Fredriksen, A. B. & Bogen, B. DNA vaccine that targets hemagglutinin to mhc class ii molecules rapidly induces antibody-mediated protection against influenza. J. Immunol. 191, 3221\u20133231 (2013).","journal-title":"J. Immunol."},{"key":"59353_CR79","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed, L. J. & Muench, H. A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 27, 493\u2013497 (1938).","journal-title":"Am. J. Epidemiol."},{"key":"59353_CR80","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/nbt1143","volume":"23","author":"C Vaccaro","year":"2005","unstructured":"Vaccaro, C., Zhou, J., Ober, R. J. & Ward, E. S. Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels. Nat. Biotechnol. 23, 1283\u20131288 (2005).","journal-title":"Nat. Biotechnol."},{"key":"59353_CR81","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/ni.3680","volume":"18","author":"D Angeletti","year":"2017","unstructured":"Angeletti, D. et al. Defining B cell immunodominance to viruses. Nat. Immunol. 18, 456\u2013463 (2017).","journal-title":"Nat. Immunol."},{"key":"59353_CR82","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1126\/science.272.5259.263","volume":"272","author":"L Naldini","year":"1996","unstructured":"Naldini, L. et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263\u2013267 (1996).","journal-title":"Science"},{"key":"59353_CR83","doi-asserted-by":"publisher","first-page":"12058","DOI":"10.1128\/JVI.78.21.12058-12061.2004","volume":"78","author":"V Zennou","year":"2004","unstructured":"Zennou, V., Perez-Caballero, D., G\u00f6ttlinger, H. & Bieniasz, P. D. APOBEC3G incorporation into human immunodeficiency virus type 1 particles. J. Virol. 78, 12058\u201312061 (2004).","journal-title":"J. Virol."},{"key":"59353_CR84","doi-asserted-by":"publisher","first-page":"eabi9215","DOI":"10.1126\/scitranslmed.abi9215","volume":"14","author":"P Zhou","year":"2022","unstructured":"Zhou, P. et al. A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection. Sci. Transl. Med. 14, eabi9215 (2022).","journal-title":"Sci. Transl. Med."},{"key":"59353_CR85","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1126\/science.abc7520","volume":"369","author":"TF Rogers","year":"2020","unstructured":"Rogers, T. F. et al. Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Science 369, 956\u2013963 (2020).","journal-title":"Science"},{"key":"59353_CR86","unstructured":"Anthi, A. https:\/\/BioRender.com\/ikhc1he (2025)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59353-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59353-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59353-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T05:03:17Z","timestamp":1746075797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59353-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["59353"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-59353-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,1]]},"assertion":[{"value":"23 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"I.S., J.T.A. and M.B. are patent co-inventors for \u201cAlbumin Variants and Uses Thereof\u201d (EP3063171B1, US10208102, and US10781245). I.S., J.T.A. and T.T.G. have ownership interests in Authera AS. D.P. and K.A.H. are co-inventors of patent WO2024089258A1. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3999"}}